Filing Details
- Accession Number:
- 0001209191-12-027020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-09 13:00:00
- Reporting Period:
- 2012-05-07
- Filing Date:
- 2012-05-09
- Accepted Time:
- 2012-05-09 16:39:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1429894 | Thomas Shea | C/O Nxstage Medical, Inc. 439 South Union Street Lawrence MA 01843 | Svp Manufacturing Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-07 | 4,000 | $4.32 | 37,692 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-07 | 5,000 | $16.76 | 32,692 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-05-07 | 4,000 | $0.00 | 4,000 | $4.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 95,000 | 2009-03-31 | 2015-03-30 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2011.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.54 to $16.93. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- This stock option vests as to 25% of the underlying shares on March 31, 2009 and then in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
